Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
60
Top-10 weight
24.98%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
48
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
484.2
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | State Street Navigator Securities Lending Portfolio II | GVMXX | 24,400,789 | $24.40M | 7.93% |
| 2 | ENLIVEN THERAPEUTICS INC | — | 192,297 | $7.54M | 2.45% |
| 3 | CORCEPT THERAPEUTICS INC | — | 174,971 | $7.05M | 2.29% |
| 4 | TERNS PHARMACEUTICALS INC | — | 126,197 | $6.65M | 2.16% |
| 5 | PERRIGO CO PLC | — | 601,785 | $6.46M | 2.10% |
| 6 | AXSOME THERAPEUTICS INC | — | 37,013 | $6.26M | 2.03% |
| 7 | INNOVIVA INC | — | 263,314 | $6.14M | 1.99% |
| 8 | MERCK & CO | — | 50,800 | $6.11M | 1.98% |
| 9 | PFIZER INC | — | 216,247 | $6.07M | 1.97% |
| 10 | ROYALTY PHARMA PLC | — | 126,441 | $6.07M | 1.97% |
| 11 | ELANCO ANIMAL HEALTH INC | — | 251,749 | $6.02M | 1.96% |
| 12 | JAZZ PHARMA PLC | — | 31,838 | $6.02M | 1.96% |
| 13 | ESPERION THERAPEUTICS INC NEW | — | 2,194,800 | $6.01M | 1.95% |
| 14 | EDGEWISE THERAPEUTICS INC | — | 190,497 | $6.00M | 1.95% |
| 15 | MBX BIOSCIENCES INC | — | 200,744 | $5.99M | 1.95% |
| 16 | DEFINIUM THERAPEUTICS INC | — | 316,882 | $5.99M | 1.95% |
| 17 | BRISTOL-MYERS SQUIBB CO | — | 98,425 | $5.97M | 1.94% |
| 18 | ANI PHARMACEUTICALS INC | — | 77,382 | $5.95M | 1.93% |
| 19 | JOHNSON&JOHNSON | — | 24,295 | $5.94M | 1.93% |
| 20 | TARSUS PHARMACEUTICALS INC | — | 84,481 | $5.93M | 1.92% |
| 21 | TREVI THERAPEUTICS INC | — | 494,432 | $5.90M | 1.92% |
| 22 | PACIRA BIOSCIENCES INC | — | 258,586 | $5.84M | 1.90% |
| 23 | ZOETIS INC CL A | — | 49,282 | $5.83M | 1.89% |
| 24 | CRINETICS PHARMACEUTICALS INC | — | 159,642 | $5.80M | 1.88% |
| 25 | NEKTAR THERAPEUTICS | — | 80,506 | $5.79M | 1.88% |
| 26 | LIQUIDIA TECHNOLOGIES INC | — | 153,099 | $5.78M | 1.88% |
| 27 | AMNEAL PHARM INC | — | 464,477 | $5.77M | 1.88% |
| 28 | HARMONY BIOSCIENCES HOLDINGS INC | — | 205,054 | $5.74M | 1.87% |
| 29 | SUPERNUS PHARMACEUTICALS INC | — | 110,926 | $5.73M | 1.86% |
| 30 | VIATRIS INC | — | 422,585 | $5.71M | 1.85% |
| 31 | XERIS BIOPHARMA HOLDINGS INC | — | 975,649 | $5.66M | 1.84% |
| 32 | HARROW INC | — | 159,813 | $5.64M | 1.83% |
| 33 | ORGANON & CO | — | 922,423 | $5.53M | 1.79% |
| 34 | NUVATION BIO INC | — | 1,286,168 | $5.52M | 1.79% |
| 35 | PHIBRO ANIMAL HEALTH CORP CL A | — | 99,625 | $5.51M | 1.79% |
| 36 | AMYLYX PHARMACEUTICALS INC | — | 395,413 | $5.50M | 1.79% |
| 37 | INDIVIOR PHARMACEUTICALS INC | — | 179,821 | $5.48M | 1.78% |
| 38 | COLLEGIUM PHARMACEUTICAL INC | — | 165,736 | $5.48M | 1.78% |
| 39 | LILLY ELI and CO | — | 5,904 | $5.43M | 1.76% |
| 40 | PRESTIGE CONSUMER HEALTHCARE INC | — | 91,089 | $5.40M | 1.75% |
| 41 | LIGAND PHARMACEUTICALS | — | 26,684 | $5.33M | 1.73% |
| 42 | OCULAR THERAPEUTIX INC | — | 621,423 | $5.26M | 1.71% |
| 43 | OMEROS CORP | — | 494,846 | $5.23M | 1.70% |
| 44 | EYEPOINT PHARMACEUTICALS INC | — | 395,677 | $5.10M | 1.66% |
| 45 | ALUMIS INC | — | 224,127 | $4.94M | 1.60% |
| 46 | AMPHASTAR PHARMACEUTICALS INC | — | 227,681 | $4.46M | 1.45% |
| 47 | PHATHOM PHARMACEUTICALS INC | — | 398,901 | $4.43M | 1.44% |
| 48 | THERAVANCE BIOPHARMA INC | — | 268,815 | $4.36M | 1.42% |
| 49 | RAPPORT THERAPEUTICS INC | — | 134,504 | $4.21M | 1.37% |
| 50 | ARVINAS INC | — | 362,073 | $3.84M | 1.25% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.